Identify a monoclonal antibody that inhibits the action of the HER2 protein in breast cancer.

Question

Quizplus · Accepted Answer

Trastuzumab is a monoclonal antibody that specifically targets and inhibits the action of the HER2 protein, which is overexpressed in approximately 25% of breast cancers. Cetuximab targets the epidermal growth factor receptor (EGFR), which is not typically overexpressed in breast cancer, while naproxen and ibuprofen are non-steroidal anti-inflammatory drugs that do not target HER2 at all.

Identify a Monoclonal Antibody That Inhibits the Action of the HER2